First randomized trial of remdesivir suggests antiviral drug is not associated with significant clinical benefits, more research needed
Wednesday, April 29, 2020 - 13:21
in Health & Medicine
Treatment with the antiviral drug remdesivir does not speed recovery from COVID-19 compared with placebo in hospitalized patients who are critically ill, according to the first randomized trial of its kind involving 237 adults from 10 hospitals in Wuhan, China.